In order to make patients with rare diseases live healthily, why do you need to spend 700 thousand just for a shot?

Because the research and development of rare disease drugs requires a lot of time and economic costs, and the consumer groups of rare disease drugs are relatively small, in order to ensure income, we can only increase the price of drugs. In order to ensure the survival of patients with rare diseases, they must be injected with 70. 1 10,000 needles of rare drugs. Many netizens who don't know the truth can't help but vomit. Pharmaceutical companies are too black-hearted The relevant departments did not play a role, leaving many patients with no money to treat diseases. In fact, the truth is not as simple as we thought. It is not without reason that these drugs are so expensive.

First, research and development costs are high.

The research and development cost of drugs for rare diseases is very high. According to statistics, the success rate of research and development of rare disease drugs is less than 20%, which means that many drugs have to go through many obstacles before they can be approved for marketing. Among many obstacles, researchers need to invest a lot of money and time and face the risk of failure anytime and anywhere, which invisibly increases the cost of drugs.

Second, use small groups.

Drugs for rare diseases are mainly aimed at rare patients, and the proportion of these people is usually very small, perhaps only a few million 1. In order to ensure efficiency, pharmaceutical companies can recover costs as soon as possible in a short period of time, which can only increase the price of drugs. Pharmaceutical companies are profitable in doing business, and it is impossible to make selfless contributions. And we think about it in turn, why are some drugs for lowering blood pressure and blood sugar so cheap? It is precisely because of the large number of users that almost two out of every 10 people need to use it. Even if the drug price is cheaper, some pharmaceutical companies can make small profits but quick turnover, recover their costs and make profits in the fastest time.

Many people are gratified by the news that the negotiation of high-priced medicine medical insurance is successful, and believe that more patients can be treated in the future. It can also be seen that the relevant departments have been working hard for patients with rare diseases. So don't just spit out pharmaceutical companies or related departments. Many things are not as simple as they seem. ?